No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 1.5x · 10Y median 1.6x · 39th percentile · as of Oct 5, 2026
Annualized revenue (TTM) · by quarter, last 34
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T13:21:15.588Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T13:21:15.588Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T13:21:15.588Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T13:21:15.588Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T13:21:15.588Z. Latest historical point 2022-04-05.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T13:21:15.588Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T13:21:15.588Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T13:21:15.588Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Cognyte Software Ltd. (CGNT) stock was $8.77 as of Oct 5, 2026, 4:00 PM EDT, up 0.34% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +3.9% · 3-year avg +24.5%/yr · 5-year avg -15.6%/yr
Cognyte Software Ltd., established in Herzliya, Israel, in 2020, delivers sophisticated investigative analytics software to a global array of governmental organizations and commercial businesses. Its flagship offering, branded "Actionable Intelligence for a Safer World," is an open-source platform specifically engineered to expedite and bolster the efficacy of investigations.
Software - Infrastructure · Herzliya, TA
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-01-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-01-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Next Earnings Date
Dec 8, 2026
63 days away
EPS Estimate
0.13
Revenue Est.
$112.86M
Last Quarter Results
EPS
$0.15
vs Estimate
$0.09
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1CGNT | $646.40M | $8.77 | +0.34% | +3.89% | -15.64% | N/A | N/A |
| 2GDYN | $636.03M | $7.84 | -2.24% | -7.08% | -23.01% | N/A | vs CGNT |
| 3CLMB | $629.42M | $33.73 | +2.84% | -3.46% | +39.44% | +25.28% | vs CGNT |
| 4CCSI | $669.32M | $36.38 | +2.88% | +30.65% | -7.93% | N/A | vs CGNT |
| 5INDI | $614.85M | $2.91 | -2.02% | -31.88% | -24.23% | N/A | vs CGNT |
| 6LPTH | $678.75M | $10.81 | -2.08% | +38.91% | +38.78% | +19.97% | vs CGNT |
forward FY estimate
18.56
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$109.24M
vs Estimate
$108.51M
Consensus Rating
Based on 3 analysts
Average Price Target
$12.33
+40.6% upside
Low
$10.00
Current
$8.77
High
$14.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Oct 2026 | $0.12 | $0.12 | $0.12 | 2 |
| Quarter ending Jan 2027 | $0.17 | $0.17 | $0.17 | 2 |
| Quarter ending Apr 2027 | $0.16 | $0.16 | $0.16 | 1 |
| Quarter ending Jul 2027 | $0.18 | $0.19 | $0.19 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $0.46 | $0.47 | $0.48 | 2 |
| FY 2028 | $0.75 | $0.77 | $0.77 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Oct 2026 | $111.40M | $112.86M | $114.76M | 2 |
| Quarter ending Jan 2027 | $117.75M | $119.29M | $121.31M | 2 |
| Quarter ending Apr 2027 | $114.79M | $116.29M | $118.25M | 1 |
| Quarter ending Jul 2027 | $118.43M | $119.98M | $122.01M | 1 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Jan 31, 2027, matching Key Metrics.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2027 | $440.98M | $446.87M | $449.82M | 3 |
| FY 2028 | $486.57M | $493.07M | $496.33M | 2 |
